GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win aliu Fri, 11/12/2021 – 11:43 More: GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win Source: fierce
read moreAstraZeneca’s star China business slows on Tagrisso price cut, but Alexion may come to the rescue aliu Fri, 11/12/2021 – 10:02 More: AstraZeneca’s star China business slows on Tagrisso price cut, but Alexion may come to the rescue Source: fierce
read moreJohnson & Johnson to spin out consumer health business in new publicly traded company kdunleavy Fri, 11/12/2021 – 07:48 More: Johnson & Johnson to spin out consumer health business in new publicly traded company Source: fierce
read moreThe draft guidance has been published following an evaluation of new evidence on the use of the treatment More: NICE ‘no’ for BioMarin’s Vimizin Source: News
read moreAPL is an acute leukaemia, meaning it develops quickly and requires immediate treatment More: New drug combination highly effective in children with leukaemia Source: News
read moreResearchers have said that next generation vaccines for COVID-19 should aim to induce a response against ‘replication proteins’ More: New COVID-19 vaccines could target replication proteins Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals